BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17138133)

  • 1. Nucleic acid-based marker approaches to urologic cancers.
    Veltri RW; Makarov DV
    Urol Oncol; 2006; 24(6):510-27. PubMed ID: 17138133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
    Netto GJ
    Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic and prognostic biomarkers: genomic applications in urological malignancies.
    Netto GJ; Epstein JI
    Pathology; 2010 Jun; 42(4):384-94. PubMed ID: 20438413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor inhibitory factors in urologic malignancies].
    Uemura H
    Hinyokika Kiyo; 2008 Jan; 54(1):49-52. PubMed ID: 18260361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor markers in urological malignancies].
    Kuriyama M
    Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour suppressor genes in urinary tract oncology.
    Brewster SF; Gingell JC; Brown KW
    Br J Urol; 1992 Dec; 70(6):585-90. PubMed ID: 1336697
    [No Abstract]   [Full Text] [Related]  

  • 9. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular biology advances and perspectives in urology].
    Feria Bernal G; Arroyo Kuribreña JC
    Rev Invest Clin; 2003; 55(2):243-7. PubMed ID: 12827935
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].
    Müller M; Goessl C; Krause H; Miller K
    Urologe A; 2003 May; 42(5):660-8. PubMed ID: 12750801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary bladder tumor markers.
    Lokeshwar VB; Selzer MG
    Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The "proteomics forum". Interdisciplinary proteome research by the Essen University Clinic].
    Goebell PJ; Rübben H; Müller G; Rettenmeier AW
    Urologe A; 2007 Sep; 46(9):1157-60. PubMed ID: 17605121
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of methylation in urological tumours.
    van der Heijden AG
    Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited urologic malignant disorders: nursing implications.
    Middelton L; Lessick M
    Urol Nurs; 2003 Feb; 23(1):15-8, 23-9; quiz 30. PubMed ID: 12677717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.
    Ralla B; Stephan C; Meller S; Dietrich D; Kristiansen G; Jung K
    Crit Rev Clin Lab Sci; 2014 Aug; 51(4):200-31. PubMed ID: 24878357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cytogenetic events in urologic tumors.
    Klein EA; Fair WR; Chaganti RS
    Semin Urol; 1988 Feb; 6(1):2-21. PubMed ID: 2838875
    [No Abstract]   [Full Text] [Related]  

  • 20. The emerging role of epigenetics in urological cancers.
    Ramachandran K; Soloway MS; Singal R; Manoharan M
    Can J Urol; 2007 Jun; 14(3):3535-41. PubMed ID: 17594743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.